Lancaster A, Carlson V, Pelt CE, et al. - This study was carried out to include 11 tibial plateau fractures in elderly patients with pre-existing osteoarthritis who were treated with a primary total hip arthroplasty (THA) between 2015 and 2019. This study was attempted to examine outcomes with an implant that is often categorized as an antibiotic coated prostheses (ACPs) spacer, the Zimmer-Biomet StageOne Select femoral spacer (ZBSO). Researchers conducted a retrospective review of 63 patients who had undergone placement of a ZBSO. Individuals were matched based on if or not an extended trochanteric osteotomy (ETO) was conducted applying Fischer’s exact and t-tests. The data indicated that ZBSO spacer has overall complication rates similar to the previously reported spacer series. According to the data, in the setting of ETO, though the ZBSO looks like an ACP spacer, it behaves like a molded or handmade spacer with a high rate of spacer fracture (25%) due to the small diameter of the core. The results considered that this implant should be applied with caution in combination with an ETO.